BACKGROUND: The impact of gender on major natural history endpoints in heart failure (HF) has not been examined in a propensity-matched study. METHODS: Of the 7788 chronic systolic and diastolic HF patients in the Digitalis Investigation Group trial 1926 were women. Propensity scores for female gender were used to assemble a cohort of 1669 pairs of men and women who were well-balanced on 32 measured baseline characteristics. Matched hazard ratios (HR) and 95% confidence intervals (CI) for outcomes associated with female gender were calculated using stratified Cox regression models. RESULTS:All-cause mortality occurred in 36% (rate, 1256/10,000 person-years) and 30% (rate, 1008/10,000 person-years) of matched men and women respectively during 5 years of follow up (HR when women were compared with men, 0.82, 95% CI, 0.72-0.94, P=0.004). Female gender was also associated with reduced cardiovascular mortality (matched HR, 0.85; 95% CI, 0.73-0.99, P=0.037) and a trend toward reduced non-cardiovascular mortality (matched HR, 0.73; 95% CI, 0.53-1.00; P=0.053). All-cause hospitalization occurred in 67% (rate, 4003/10,000 person-years) and 65% (rate, 3762/10,000 person-years) matched male and female patients respectively (HR for women, 1.03, 95% CI, 0.93-1.15, P=0.538). Female gender was not associated with cardiovascular or HF hospitalization but was associated with hospitalization due to unstable angina pectoris (matched HR, 1.38; 95%CI, 1.11-1.72; P=0.003) and stroke (matched HR, 0.65; 95%CI, 0.46-0.92; P=0.014). CONCLUSIONS: In patients with chronic HF, female gender has a significant independent association with improved survival but has no association with all-cause, cardiovascular, or HF hospitalizations. Published by Elsevier Ireland Ltd.
RCT Entities:
BACKGROUND: The impact of gender on major natural history endpoints in heart failure (HF) has not been examined in a propensity-matched study. METHODS: Of the 7788 chronic systolic and diastolic HFpatients in the Digitalis Investigation Group trial 1926 were women. Propensity scores for female gender were used to assemble a cohort of 1669 pairs of men and women who were well-balanced on 32 measured baseline characteristics. Matched hazard ratios (HR) and 95% confidence intervals (CI) for outcomes associated with female gender were calculated using stratified Cox regression models. RESULTS: All-cause mortality occurred in 36% (rate, 1256/10,000 person-years) and 30% (rate, 1008/10,000 person-years) of matched men and women respectively during 5 years of follow up (HR when women were compared with men, 0.82, 95% CI, 0.72-0.94, P=0.004). Female gender was also associated with reduced cardiovascular mortality (matched HR, 0.85; 95% CI, 0.73-0.99, P=0.037) and a trend toward reduced non-cardiovascular mortality (matched HR, 0.73; 95% CI, 0.53-1.00; P=0.053). All-cause hospitalization occurred in 67% (rate, 4003/10,000 person-years) and 65% (rate, 3762/10,000 person-years) matched male and female patients respectively (HR for women, 1.03, 95% CI, 0.93-1.15, P=0.538). Female gender was not associated with cardiovascular or HF hospitalization but was associated with hospitalization due to unstable angina pectoris (matched HR, 1.38; 95%CI, 1.11-1.72; P=0.003) and stroke (matched HR, 0.65; 95%CI, 0.46-0.92; P=0.014). CONCLUSIONS: In patients with chronic HF, female gender has a significant independent association with improved survival but has no association with all-cause, cardiovascular, or HF hospitalizations. Published by Elsevier Ireland Ltd.
Authors: M C de Bruyne; A Mosterd; A W Hoes; J A Kors; D A Kruijssen; J H van Bemmel; A Hofman; D E Grobbee Journal: Epidemiology Date: 1997-09 Impact factor: 4.822
Authors: K F Adams; C A Sueta; M Gheorghiade; C M O'Connor; T A Schwartz; G G Koch; B Uretsky; K Swedberg; W McKenna; J Soler-Soler; R M Califf Journal: Circulation Date: 1999-04-13 Impact factor: 29.690
Authors: M Iriarte; R Caso; N Murga; J M Faus; D Sagastagoitia; E Molinero; M López de Argumedo; J Boveda Journal: Am J Cardiol Date: 1995-02-15 Impact factor: 2.778
Authors: O James Ekundayo; Chris Adamopoulos; Mustafa I Ahmed; Bertram Pitt; James B Young; Jerome L Fleg; Thomas E Love; Xuemei Sui; Gilbert J Perry; David S Siscovick; George Bakris; Ali Ahmed Journal: Int J Cardiol Date: 2009-01-09 Impact factor: 4.164
Authors: Yan Zhang; Meredith L Kilgore; Tarun Arora; Marjan Mujib; O James Ekundayo; Inmaculada B Aban; Margaret A Feller; Ravi V Desai; Thomas E Love; Richard M Allman; Gregg C Fonarow; Ali Ahmed Journal: Int J Cardiol Date: 2011-11-25 Impact factor: 4.164
Authors: Beverly R Williams; Yan Zhang; Patricia Sawyer; Marjan Mujib; Linda G Jones; Margaret A Feller; O James Ekundayo; Inmaculada B Aban; Thomas E Love; Amy Lott; Ali Ahmed Journal: J Gerontol A Biol Sci Med Sci Date: 2011-09-07 Impact factor: 6.053
Authors: Ali Ahmed; Gregg C Fonarow; Yan Zhang; Paul W Sanders; Richard M Allman; Donna K Arnett; Margaret A Feller; Thomas E Love; Inmaculada B Aban; Raynald Levesque; O James Ekundayo; Louis J Dell'Italia; George L Bakris; Michael W Rich Journal: Am J Med Date: 2012-02-07 Impact factor: 4.965
Authors: Vittal Hejjaji; Yuanyuan Tang; Theresa Coles; Philip G Jones; Bryce B Reeve; Robert J Mentz; Erica S Spatz; Shannon M Dunlay; Brittany Caldwell; Anindita Saha; Michelle E Tarver; Andy Tran; Krishna K Patel; Debra Henke; Ileana L Piña; John A Spertus Journal: Circ Heart Fail Date: 2021-09-01 Impact factor: 10.447
Authors: Prakash Deedwania; Kanan Patel; Gregg C Fonarow; Ravi V Desai; Yan Zhang; Margaret A Feller; Fernando Ovalle; Thomas E Love; Inmaculada B Aban; Marjan Mujib; Mustafa I Ahmed; Stefan D Anker; Ali Ahmed Journal: Int J Cardiol Date: 2013-05-31 Impact factor: 4.164
Authors: Ramon F Abarquez; Paul Ferdinand M Reganit; Carmen N Chungunco; Jean Alcover; Felix Eduardo R Punzalan; Eugenio B Reyes; Elleen L Cunanan Journal: ASEAN Heart J Date: 2016-03-08
Authors: Viera Stubnova; Ingrid Os; Aud Høieggen; Marit D Solbu; Morten Grundtvig; Arne S Westheim; Dan Atar; Bård Waldum-Grevbo Journal: BMC Cardiovasc Disord Date: 2019-01-05 Impact factor: 2.298